Clinical and biological distinctions between type I and type II acquired angioedema

被引:32
作者
Bouillet-Claveyrolas, L [1 ]
Ponard, D [1 ]
Drouet, C [1 ]
Massot, C [1 ]
机构
[1] Univ Grenoble 1, Grenoble Univ Hosp, Grenoble, France
关键词
D O I
10.1016/S0002-9343(03)00396-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:420 / 421
页数:2
相关论文
共 5 条
[1]   AUTOIMMUNE C1 INHIBITOR DEFICIENCY - REPORT OF 8 PATIENTS [J].
CICARDI, M ;
BISIANI, G ;
CUGNO, M ;
SPATH, P ;
AGOSTONI, A .
AMERICAN JOURNAL OF MEDICINE, 1993, 95 (02) :169-175
[2]   ACTIVATION OF THE CONTACT SYSTEM AND FIBRINOLYSIS IN AUTOIMMUNE ACQUIRED ANGIOEDEMA - A RATIONALE FOR PROPHYLACTIC USE OF TRANEXAMIC ACID [J].
CUGNO, M ;
CICARDI, M ;
AGOSTONI, A .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (05) :870-876
[3]   A SENSITIVE METHOD TO ASSAY BLOOD COMPLEMENT C1 INHIBITOR ACTIVITY [J].
DROUET, C ;
ALIBEU, C ;
PONARD, D ;
ARLAUD, GJ ;
COLOMB, MG .
CLINICA CHIMICA ACTA, 1988, 174 (02) :121-130
[4]   Acquired C1 esterase inhibitor deficiency - In Response [J].
Markovic, SN ;
Inwards, DJ ;
Phyliky, RP .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (10) :839-839
[5]   Bradykinin-mediated angioedema [J].
Nussberger, J ;
Cugno, M ;
Cicardi, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (08) :621-622